Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Good progression reported in phase II trial of COLAL-PRED in ulcerative colitis

Dec. 19, 2001

XTL Biopharmaceuticals extends human lactoferrin research program with AM-Pharma

Dec. 19, 2001

Tularik discovers new series of HCV polymerase inhibitors

Dec. 14, 2001

Wide series of macrocyclic compounds for HCV designed and disclosed in recent patent

Dec. 13, 2001

Synsorb discontinues Synsorb-Cd development program

Dec. 13, 2001

Amsterdam Molecular Therapeutics receives grant for LPL gene therapy

Dec. 13, 2001

Encouraging results reported from phase IIa trial of XTL-001 in chronic hepatitis B patients

Dec. 12, 2001

Pioglitazone prevents profibrogenic responses in the liver

Dec. 11, 2001

Incara and FDA meet to discuss plans for liver cell program prior to IND submission

Dec. 10, 2001

Agents for hepatitis C under study at Vertex

Dec. 7, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...